NORDITROPIN HGH AT 3 DOSE LEVELS ON GROWTH VELOCITY IN GH DEFICIENT CHILDREN

3 个剂量水平的去甲肾上腺素 HGH 对 GH 缺乏儿童生长速度的影响

• 批准号: 6118158
• 负责人: ALAN D ROGOL
• 金额: $ 3.03万
• 依托单位: UNIVERSITY OF VIRGINIA
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/6118158
• 关键词: body height; child (0-11); child physical development; clinical research; dosage; drug administration rate /duration; drug screening /evaluation; human subject; human therapy evaluation; longitudinal human study; pituitary dwarfism; somatotropin

The principle objective is to evaluate and compare safety and growth velocity effectiveness of graded Norditropin dose levels administered to GH deficient children. The second objective is to determine safety and effectiveness of chronic Norditropin administration and follow-up until adult height is attained. We are continuing to enroll subjects.

主要目标是评估和比较安全性和增长 去甲肾上腺素分级剂量水平的速度有效性 GH 缺乏儿童。 第二个目标是确定安全性 长期去甲肾上腺素给药和随访的有效性 直至达到成年身高。 我们正在继续招收科目。